Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Dec 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,233,000
$137.51 P/Share
|
|
Dec 14
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,034
-38.56%
|
$3,955,372
$158.42 P/Share
|
|
Dec 14
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,034
+25.96%
|
$400,544
$16.63 P/Share
|
|
Dec 14
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-1.15%
|
$3,260,000
$163.63 P/Share
|
|
Dec 14
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.57%
|
$0
$0.99 P/Share
|
|
Dec 11
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.58%
|
$1,767,360
$160.12 P/Share
|
|
Dec 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
13,832
-0.09%
|
$2,074,800
$150.3 P/Share
|
|
Dec 09
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Dec 09
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,530,000
$170.0 P/Share
|
|
Dec 07
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-35.05%
|
$3,160,000
$158.58 P/Share
|
|
Dec 07
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+38.26%
|
$280,000
$14.45 P/Share
|
|
Dec 04
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.56%
|
$1,678,992
$152.72 P/Share
|
|
Dec 03
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,430,000
$143.59 P/Share
|
|
Dec 03
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.57%
|
$1,430,000
$143.59 P/Share
|
|
Dec 03
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.57%
|
$0
$0.99 P/Share
|
|
Dec 02
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.57%
|
$1,380,000
$138.57 P/Share
|
|
Dec 02
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.57%
|
$0
$0.99 P/Share
|
|
Dec 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Dec 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,242,000
$138.57 P/Share
|
|
Dec 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
3,929
-0.04%
|
$699,362
$178.0 P/Share
|
|
Nov 30
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-34.43%
|
$2,960,000
$148.2 P/Share
|
|
Nov 30
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+38.89%
|
$300,000
$15.19 P/Share
|
|
Nov 27
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
21,046
-0.28%
|
$2,567,612
$122.24 P/Share
|
|
Nov 25
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Nov 25
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$891,000
$99.2 P/Share
|
|
Nov 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.06%
|
$480,000
$96.91 P/Share
|
|
Nov 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.29%
|
$1,500,000
$100.23 P/Share
|
|
Nov 23
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.57%
|
$0
$0.99 P/Share
|
|
Nov 23
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-53.34%
|
$1,500,000
$100.21 P/Share
|
|
Nov 23
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+45.0%
|
$225,000
$15.68 P/Share
|
|
Nov 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
17,514
-1.82%
|
$1,663,830
$95.1 P/Share
|
|
Nov 19
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$890,000
$89.8 P/Share
|
|
Nov 18
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Nov 18
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$837,000
$93.87 P/Share
|
|
Nov 16
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-43.85%
|
$1,440,000
$96.87 P/Share
|
|
Nov 16
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+45.0%
|
$225,000
$15.68 P/Share
|
|
Nov 13
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-3.45%
|
$961,002
$87.0 P/Share
|
|
Nov 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.85%
|
$1,305,000
$87.0 P/Share
|
|
Nov 13
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.57%
|
$0
$0.99 P/Share
|
|
Nov 12
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$840,000
$84.99 P/Share
|
|
Nov 12
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.07%
|
$430,000
$86.28 P/Share
|
|
Nov 12
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Nov 11
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$693,000
$77.05 P/Share
|
|
Nov 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
7,718
-0.09%
|
$617,440
$80.0 P/Share
|
|
Nov 09
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-62.45%
|
$1,170,000
$78.35 P/Share
|
|
Nov 09
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+45.0%
|
$225,000
$15.68 P/Share
|
|
Nov 06
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-3.33%
|
$784,266
$71.5 P/Share
|
|
Nov 05
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$710,000
$71.09 P/Share
|
|
Nov 04
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|